Exercise Evidence In Myalgic Encephalomyelitis

The latest Cochrane review currently available on exercise for chronic fatigue syndrome is the 2019 update by Larun and colleagues. It assessed whether structured exercise therapy could improve symptoms and daily functioning in people diagnosed with chronic fatigue syndrome (CFS), also called myalgic encephalomyelitis (ME/CFS).

Its findings are more measured than the phrase “exercise works” suggests. Some participants experienced less fatigue and better physical function, but the certainty of the evidence was low. The studies were also conducted before current clinical guidance placed greater emphasis on post-exertional malaise (PEM), individual pacing, and patient safety.

This distinction matters for patients, families, carers, clinicians, and researchers translating evidence into care. Activity that is tolerable for one person may trigger a prolonged symptom flare in another, particularly when it exceeds an individual’s available energy.

What The Cochrane Review Examined

The review included eight studies involving 1,518 participants. Most compared a planned exercise programme with usual care, relaxation, flexibility work, or another relatively inactive approach. Interventions varied, but several involved aerobic activity that increased gradually over time.

The review assessed outcomes including fatigue, physical functioning, sleep, depression, quality of life, and adverse events. It did not examine every form of movement or every presentation of ME/CFS, and many studies recruited people who were able to attend outpatient programmes and participate in repeated assessments.

That limits how broadly the results can be applied. People with severe or very severe ME/CFS, significant orthostatic intolerance, marked sensory sensitivity, or pronounced PEM were under-represented in the research.

What Benefits Were Reported

Compared with passive or usual-care controls, exercise therapy probably reduced fatigue and improved physical functioning for some participants. The review also identified possible improvements in sleep and depression, although confidence in these findings was limited by the quality and design of the underlying studies.

The results do not establish that exercise restores health, eliminates ME/CFS, or produces the same benefit for every patient. Improvements were generally measured using questionnaires and functional assessments, and the programmes differed in intensity, supervision, duration, and expectations.

Quality of life remained less certain. A person may report a modest improvement in fatigue while still being unable to work, study, manage personal care, or maintain social activities. These outcomes should therefore be considered separately rather than combined into a single claim of recovery.

Why Post-Exertional Malaise Changes The Interpretation

PEM is a delayed and disproportionate worsening of symptoms after physical, cognitive, emotional, or sensory exertion. It may appear hours or days after activity and can last for days, weeks, or longer. This feature makes a fixed progression in exercise especially problematic for people whose symptoms fluctuate.

The Cochrane review did not provide strong evidence about how exercise affects patients with substantial PEM. Adverse events were not clearly more common in exercise groups, but harms were inconsistently defined and reported. A lack of recorded harm is therefore not the same as proof that a programme is safe for every person.

Current clinical practice has moved away from automatically increasing activity according to a predetermined schedule. The 2021 NICE guideline advises against graded exercise therapy delivered through fixed incremental increases. It supports personalised energy management, in which activity remains within a person’s current limits and changes are guided by symptoms.

Reading The Evidence Alongside Current Care

The review is useful because it brings together controlled studies, but it should be read alongside newer guidance and the lived experience of people with ME/CFS. Evidence translation requires attention to who was studied, how outcomes were measured, and whether the intervention reflects care offered today.

A flexible activity plan may include gentle movement, position changes, stretching, or essential daily tasks. For some people, even these activities need to be brief, supported, and followed by adequate rest. For others, increasing activity is possible only after a stable baseline has been established.

Individualised Rehabilitation Requires Care

An appropriate management plan begins with assessment rather than an exercise prescription. Clinicians may need to consider PEM, sleep problems, pain, dizziness, orthostatic intolerance, sensory overload, medication effects, nutrition, and mental health without implying that ME/CFS is primarily psychological.

Medication review can also be relevant when fatigue, dizziness, or other symptoms are difficult to interpret. Resources on safer medication choices explain how pharmacogenomics may help identify some genetic differences affecting drug response, although testing does not diagnose ME/CFS or replace clinical judgement.

Shared decision-making is central. A patient should be able to discuss expected benefits, possible deterioration, alternatives, and how a programme will be paused or changed. Families and carers can help monitor delayed symptoms, while clinicians should avoid treating an inability to progress as a failure of motivation.

Practical Principles For Activity Management

Energy management is not the same as avoiding all movement. It is a way of balancing physical, cognitive, emotional, and sensory demands with available energy. The aim is to reduce boom-and-bust cycles, in which a relatively active day is followed by a severe crash.

Useful principles include:

• Establish a sustainable baseline before attempting any increase in activity.
• Track delayed symptoms, including fatigue, pain, cognitive difficulty, dizziness, and sleep disruption.
• Change one variable at a time and use small adjustments rather than automatic weekly increases.
• Stop or reduce activity when PEM emerges, and allow recovery before reassessing.
• Agree on clear review points with a clinician, physiotherapist, or occupational therapist familiar with ME/CFS.

People with severe symptoms may require help with positioning, personal care, nutrition, communication, and pressure-area prevention before any exercise discussion. The safest intervention may be conserving energy and preventing harm, rather than pursuing conditioning.

Implications For Research And Health Services

The Cochrane findings highlight major gaps in the evidence. Future trials need consistent definitions of ME/CFS and PEM, better reporting of adverse events, longer follow-up, and inclusion of people with moderate, severe, and very severe illness. Studies should report whether participants improved, remained stable, or experienced delayed deterioration.

Research should also compare flexible pacing and symptom-contingent rehabilitation with other forms of support. Patient-reported outcomes, employment or education participation, independence, and healthcare use may be more meaningful than fitness measures alone.

Collaborative organisations such as the Brisbane Diamantina network can help connect health services, universities, research institutes, and communities. That kind of partnership supports translation of emerging evidence into ethical studies, informed clinical practice, and care that reflects the needs of patients and carers.

The review does not justify a universal exercise programme, nor does it show that movement is inherently harmful. It supports a careful, individualised interpretation: some people may benefit from appropriately adapted activity, while others need stabilisation, symptom management, and protection from overexertion. Health services should apply the evidence alongside current guidelines and the patient’s own response.